HCPCS codes

22720 HCPCS codes with hospital pricing data in the network.

• HCPCS J1956 — Levofloxacin 500 mg IV infusionAI (2355 hospitals, 93,101–132,800 samples)
• HCPCS J7195 — Factor IX injection, per international unitAI (1699 hospitals, 129,596–129,848 samples)
• HCPCS J1596 — Glycopyrrolate injection 0.2 mg/mLAI (2168 hospitals, 61,096–125,851 samples)
• HCPCS J1439 — Injection of ferric carboxymaltose (iron), per 1 mgAI (2013 hospitals, 119,135–122,753 samples)
• HCPCS J9263 — Oxaliplatin injection, 0.5 mgAI (2013 hospitals, 110,763–121,617 samples)
• HCPCS G0103 — PSA blood test for prostate cancer screeningAI (2259 hospitals, 99,176–121,586 samples)
• HCPCS G0439 — Yearly wellness visit with prevention plan follow-upAI (1367 hospitals, 114,581–120,305 samples)
• HCPCS P9016 — Leukocyte-reduced red blood cell transfusionAI (2498 hospitals, 59,108–118,535 samples)
• HCPCS J1580 — Gentamicin sulfate injection, 40 mg/mLAI (2379 hospitals, 82,149–118,275 samples)
• HCPCS C1892 — Telescopic safety introducer sheathAI (1802 hospitals, 14,666–111,983 samples)
• HCPCS G0279 — Diagnostic digital breast tomosynthesisAI (1960 hospitals, 91,693–107,947 samples)
• HCPCS J0613 — 505WGCAGL1G/NACL 50MLINJ (1942 hospitals, 100,862–107,297 samples)
• HCPCS J0166 — Epinephrine injection, 0.1 mgAI (1442 hospitals, 97,100–103,130 samples)
• HCPCS J0897 — Denosumab injection, per 1 mgAI (2283 hospitals, 88,337–102,404 samples)
• HCPCS Q9966 — Low-osmolar contrast dye, 1 mLAI (2149 hospitals, 61,594–102,157 samples)
• HCPCS J0780 — Prochlorperazine injection, 10 mg per 2 mLAI (2359 hospitals, 36,189–100,881 samples)
• HCPCS C2623 — Balloon dilation catheterAI (1717 hospitals, 10,570–100,309 samples)
• HCPCS J0295 — Ampicillin and sulbactam injection, 3 gAI (2388 hospitals, 29,304–100,035 samples)
• HCPCS C1893 — Transseptal access sheath delivery systemAI (1670 hospitals, 12,737–99,353 samples)
• HCPCS J0881 — Darbepoetin alfa injection, per microgram (non-dialysis use)AI (2104 hospitals, 91,923–98,295 samples)
• HCPCS J2765 — Metoclopramide hydrochloride injection, 5 mg per mLAI (2372 hospitals, 50,478–97,575 samples)
• HCPCS J3291 — Tranexamic acid injection, 5 mgAI (588 hospitals, 95,168–95,942 samples)
• HCPCS J0185 — Injection of aprepitant, per 1 mgAI (1592 hospitals, 91,986–92,913 samples)
• HCPCS J1459 — Privigen immune globulin IV infusion, 10 gramsAI (1968 hospitals, 85,261–91,336 samples)
• HCPCS J9144 — Daratumumab and hyaluronidase injectionAI (1815 hospitals, 85,568–88,646 samples)
• HCPCS C8929 — Heart ultrasound with Doppler and contrastAI (2005 hospitals, 63,129–88,311 samples)
• HCPCS C1732 — Decapolar navigation catheter, D-curve, 7 French, 115 cmAI (1581 hospitals, 12,682–87,814 samples)
• HCPCS J2710 — Neostigmine injection, 10 mg per 10 mLAI (2212 hospitals, 42,047–87,209 samples)
• HCPCS C1767 — Condylar head screw (implant)AI (1818 hospitals, 9,785–87,059 samples)
• HCPCS J0153 — Adenosine IV injection, 6 mg/2 mLAI (2355 hospitals, 31,564–84,394 samples)
• HCPCS B4088 — Low-profile feeding tube for stomach or jejunumAI (963 hospitals, 8,598–83,136 samples)
• HCPCS C1882 — Heart failure cardiac resynchronization defibrillator deviceAI (1754 hospitals, 8,411–81,122 samples)
• HCPCS C1773 — Single-loop snare retrieval kit for vena cava deviceAI (1831 hospitals, 15,233–79,592 samples)
• HCPCS J2060 — Lorazepam injection 2 mg/mLAI (2402 hospitals, 24,554–79,373 samples)
• HCPCS C1733 — Diagnostic catheter, 7 French blood-pressure-transducer-compatible catheterAI (1632 hospitals, 11,321–79,145 samples)
• HCPCS Q0144 — Azithromycin 250 mg by mouthAI (1233 hospitals, 8,614–78,589 samples)
• HCPCS C1785 — Assurity dual-chamber pacemaker deviceAI (1820 hospitals, 8,848–78,382 samples)
• HCPCS J3370 — Vancomycin injection, 1 gramAI (1446 hospitals, 20,789–78,002 samples)
• HCPCS J3290 — Tranexamic acid IV solutionAI (1111 hospitals, 70,690–77,125 samples)
• HCPCS J2470 — Pantoprazole injection, 40 mg IVAI (2131 hospitals, 52,872–76,956 samples)
• HCPCS J2272 — Morphine sulfate injectionAI (1865 hospitals, 32,453–76,688 samples)
• HCPCS J1920 — Labetalol injection, prefilled syringesAI (2139 hospitals, 23,152–76,063 samples)
• HCPCS J0689 — Cefazolin injection, 500 mgAI (1364 hospitals, 69,609–74,199 samples)
• HCPCS A9150 — Miscellaneous non-prescription drugAI (398 hospitals, 21,352–74,020 samples)
• HCPCS J0612 — Calcium gluconate injection 10%AI (2311 hospitals, 55,303–73,204 samples)
• HCPCS C1787 — Handheld controller for pain neurostimulatorAI (1764 hospitals, 8,616–73,128 samples)
• HCPCS J9201 — Gemcitabine injection, 200 mgAI (2147 hospitals, 61,314–71,988 samples)
• HCPCS J2469 — Injection of palonosetron, 25 mcgAI (1962 hospitals, 58,899–71,886 samples)
• HCPCS L8614 — Cochlear implant flexible electrode, Flex 2AI (1480 hospitals, 7,506–71,595 samples)
• HCPCS J7187 — Von Willebrand factor complex injection, per unitAI (1878 hospitals, 70,093–70,876 samples)